The Longevity Shift: Strategic implications of the longevity medicine revolution
Turn longevity from trend to strategy: where should pharma play - and how to win?
Longevity is emerging as one of the most dynamic frontiers in healthcare innovation. In 2025, longevity’s not just about living longer; it’s about preserving vitality, function and independence - creating new strategic options for portfolios and go to market.
Explore the strategic implications of the longevity market revolution:
- Navigate five strategic categories, including GLP-1s
- Map assets to longevity-relevant opportunities
- Plan for regional regulatory pathways and access implications
- Distinguish consumer activation models by market
This new point of view maps the emergence of longevity medicine, the strategic implications and the growing recognition that longevity may become a defining theme in the future of medicine.